{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:04:39Z","timestamp":1794287079960,"version":"4.9.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.vaccine.2024.01.055","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T08:39:50Z","timestamp":1706344790000},"page":"1154-1159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Short term safety of BNT162b2 (Pfizer\u2013BioNTech) SARS-CoV-2 vaccine among children aged 5\u201311\u00a0years, a nationwide parental survey"],"prefix":"10.1016","volume":"42","author":[{"given":"Shirley","family":"Shapiro Ben David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Baruch Gez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-6596","authenticated-orcid":false,"given":"Limor","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rada","family":"Kovatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9440-5592","authenticated-orcid":false,"given":"Daniella","family":"Rahamim-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na'ama","family":"Shamir-Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Shahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Mizrhi-Reuveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.01.055_b0005","unstructured":"American Academy of Pediatrics. Children and COVID-19: State-Level Data Report. Available at: https:\/\/www.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/children-and-covid-19-state-level-data-report\/. Accessed January 26, 2022."},{"key":"10.1016\/j.vaccine.2024.01.055_b0010","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/apa.15962","article-title":"COVID-19 in children and the effect of schools reopening on potential transmission to household members","volume":"110","author":"Shapiro Ben David","year":"2021","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2024.01.055_b0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jpids\/piab035","article-title":"COVID-19 in a subset of hospitalized children in Israel","volume":"10","author":"Ben-Shimol","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2024.01.055_b0020","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00431-020-03684-7","article-title":"SARS-COV-2 infection in children and newborns: a systematic review","volume":"179","author":"Liguoro","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2024.01.055_b0025","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1097\/INF.0000000000003285","article-title":"Long COVID in children: observations from a designated pediatric clinic","volume":"40","author":"Ashkenazi-Hoffnung","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.01.055_b0030","unstructured":"Israeli ministry of health. COVID-19 Vaccine for Children. Hebrew. Available from: https:\/\/corona.health.gov.il\/en\/vaccine-for-covid\/under-12\/. Accessed January 26, 2022."},{"key":"10.1016\/j.vaccine.2024.01.055_b0035","doi-asserted-by":"crossref","unstructured":"Stein M, Ashkenazi-Hoffnung L, Greenberg D, Dalal I, Livni G, Chapnick G, et al. The Burden of COVID-19 in children and its prevention by vaccination: A joint statement of the Israeli pediatric association and the israeli society for pediatric infectious diseases. Vaccines (Basel) 2022; 10. Doi: 10.3390\/vaccines10010081.","DOI":"10.3390\/vaccines10010081"},{"key":"10.1016\/j.vaccine.2024.01.055_b0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jpeds.2021.07.021","article-title":"Plans to vaccinate children for coronavirus disease 2019: A survey of united states parents","volume":"237","author":"Teasdale","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2024.01.055_b0045","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1016\/j.vaccine.2022.08.030","article-title":"Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents","volume":"40","author":"Marron","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.055_b0050","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1016\/j.vaccine.2021.07.058","article-title":"Parental plans to vaccinate children for COVID-19 in New York city","volume":"39","author":"Teasdale","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.055_b0055","doi-asserted-by":"crossref","unstructured":"Urrunaga-Pastor D, Herrera-A\u00f1azco P, Uyen-Cateriano A, Toro-Huamanchumo CJ, Rodriguez-Morales AJ, Hernandez AV, et al. Prevalence and factors associated with parents\u2019 non-intention to vaccinate their children and adolescents against COVID-19 in Latin America and the Caribbean. Vaccines (Basel) 2021; 9. Doi: 10.3390\/vaccines9111303.","DOI":"10.3390\/vaccines9111303"},{"key":"10.1016\/j.vaccine.2024.01.055_b0060","doi-asserted-by":"crossref","first-page":"2028516","DOI":"10.1080\/21645515.2022.2028516","article-title":"COVID-19 vaccination in 5\u201311 years old children: Drivers of vaccine hesitancy among parents in Quebec","volume":"18","author":"Dub\u00e9","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.01.055_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13584-016-0062-y","article-title":"Vaccine hesitancy: understanding better to address better","volume":"5","author":"Kumar","year":"2016","journal-title":"Isr J Health Policy Res"},{"key":"10.1016\/j.vaccine.2024.01.055_b0070","doi-asserted-by":"crossref","unstructured":"Larson HJ, Schulz WS, Tucker JD, Smith DMD. Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr Influenza 2015; 7. Doi: 10.1371\/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4.","DOI":"10.1371\/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4"},{"key":"10.1016\/j.vaccine.2024.01.055_b0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age","volume":"386","author":"Walter","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.01.055_b0080","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.15585\/mmwr.mm705152a1","article-title":"COVID-19 vaccine safety in children aged 5\u201311 years - United States, November 3-December 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.01.055_b0085","doi-asserted-by":"crossref","unstructured":"Joseph G, Klein E, Lustig Y, Weiss-Ottolenghi Y, Asraf K, Indenbaum V, et al. Real-world immunogenicity and reactogenicity of two doses of Pfizer-BioNTech COVID-19 vaccination in children aged 5-11 years. Vaccines (Basel) 2022; 10. Doi: 10.3390\/vaccines10111954.","DOI":"10.3390\/vaccines10111954"},{"key":"10.1016\/j.vaccine.2024.01.055_b0090","unstructured":"Israeli Central Bureau of Statistics. Characterization and classification of geographical units by the socio-economic level of the population; 2015. Available from: https:\/\/din-online.info\/pdf\/lst92e.pdf."},{"key":"10.1016\/j.vaccine.2024.01.055_b0095","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-3852","article-title":"Parental hesitancy about routine childhood and influenza vaccinations: A national survey","volume":"146","author":"Kempe","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.01.055_b0100","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1016\/j.vaccine.2017.09.046","article-title":"A systematic review of factors affecting vaccine uptake in young children","volume":"35","author":"Smith","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.055_b0105","unstructured":"Israeli ministry of health. Reported side effects of COVID-19 vaccine for children aged 5-11 years. Hebrew. Available from: https:\/\/www.gov.il\/BlobFolder\/reports\/vaccine-efficacy-safety-follow-up-committee\/he\/files_publications_corona_pres-children-02022022.pdf. Page 21-24. Accessed October 1, 2023."},{"key":"10.1016\/j.vaccine.2024.01.055_b0110","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2147\/PPA.S167396","article-title":"Consumer opinions on adverse events associated with medicines and vaccines","volume":"12","author":"Aslani","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.vaccine.2024.01.055_b0115","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057313","article-title":"Safety of COVID-19 vaccination in United States children ages 5 to 11 years","volume":"150","author":"Hause","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.01.055_b0120","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.15585\/mmwr.mm7031e1","article-title":"COVID-19 vaccine safety in adolescents aged 12\u201317 years - United States, December 14, 2020-July 16, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.01.055_b0125","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.13.2100540","article-title":"Immediate side effects of Comirnaty COVID-19 vaccine: A nationwide survey of vaccinated people in Israel, December 2020 to March 2021","volume":"27","author":"Shapiro Ben David","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.01.055_b0130","doi-asserted-by":"crossref","unstructured":"Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D. Gender differences in adverse events following the Pfizer-BioNTech COVID-19 Vaccine. Vaccines (Basel) 2022; 10. Doi: 10.3390\/vaccines10020233.","DOI":"10.3390\/vaccines10020233"},{"key":"10.1016\/j.vaccine.2024.01.055_b0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"npj Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:35:23Z","timestamp":1759404923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0264410X24000677"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short term safety of BNT162b2 (Pfizer\u2013BioNTech) SARS-CoV-2 vaccine among children aged 5\u201311\u00a0years, a nationwide parental survey","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}